Howland Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Hold |
4,000
| – | – | 0.05% | 139 |
|
|
2025
Q1 | $1.08M | Hold |
4,000
| – | – | 0.05% | 146 |
|
|
2024
Q4 | $941K | Hold |
4,000
| – | – | 0.04% | 150 |
|
|
2024
Q3 | $1.1M | Hold |
4,000
| – | – | 0.05% | 144 |
|
|
2024
Q2 | $972K | Hold |
4,000
| – | – | 0.05% | 140 |
|
|
2024
Q1 | $598K | Hold |
4,000
| – | – | 0.03% | 173 |
|
|
2023
Q4 | $766K | Buy |
+4,000
| New | +$766K | 0.04% | 150 |
|
|
2023
Q3 | – | Sell |
-4,000
| Closed | -$760K | – | 246 |
|
|
2023
Q2 | $760K | Hold |
4,000
| – | – | 0.04% | 149 |
|
|
2023
Q1 | $801K | Hold |
4,000
| – | – | 0.05% | 142 |
|
|
2022
Q4 | $951K | Hold |
4,000
| – | – | 0.06% | 130 |
|
|
2022
Q3 | $801K | Buy |
+4,000
| New | +$801K | 0.05% | 132 |
|